Company / Revenue
SUTRO BIOPHARMA, INC. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$62.0M
FY2025
5-year range
$42.7M / $67.8M
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 8 years, ranging from $38M in FY2020 to $68M in FY2024.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of +10.1%.
Remained stable around $62M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- +10.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +10.1%, indicating consistent growth.
- In FY2025, revenue decreased 8.5% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.0M | -8.5% |
| FY2024 | $67.8M | +9.5% |
| FY2023 | $61.9M | +44.8% |
| FY2022 | $42.7M | -0.0% |
| FY2021 | $42.7M | +11.2% |
| FY2020 | $38.4M | -25.7% |
| FY2019 | $51.7M | -13.4% |
| FY2018 | $59.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026